ICMR

Identification of the kinase and its inhibitors that potentiates irinotecan-induced phosphorylation of the proto-oncogene EVI1 in colon cancer cells. Masters degree or integrated master's degree with first-class in Life Sciences, Biotechnology, Biochemistry, Molecular Biology, Genetics, Zoology, Chemistry from a recognized University.

Professional having B.Pharm, BAMS, B-Tech, MPH. Preference will be given to professionals having experience in Digital Health. Foster partnerships with academia, industry, and international organization to accelerate digital health adoption.

one Senior Project Assistant in the ICMR sponsored project entitled Development and Evaluation of Recombinant anti-HER2 ScFv for Targeted Breast Cancer Therapy Production, Characterization, Therapeutic Efficacy Analysis through in vitro and in vivo studies.

Development of strategies to make Host Defence Peptides pragmatically applicable for clinical use as adjunct host directed therapy against drug sensitive and resistant tuberculosis.

Towards stool-based diagnosis of colorectal cancer by developing multiplex apta-sensor panel. First Class Post Graduate Degree, including the integrated PG degrees with Two-year Experience. Second Class Post Graduate Degree, including the integrated PG degrees with PhD.

Candidates with Masters degree M.Sc. or equivalent in Microbiology, Biochemistry, Biotechnology or Life Sciences with minimum 60% aggregate marks relaxation will be given as per Govt. guideline from a recognized university with two years research experience

First Class Post Graduate Degree, including the integrated PG Degrees Life Sciences, Nanobiotechnology or Second Class Post Graduate Degree, including the integrated PG Degrees with PhD Life Sciences, Nanobiotechnology. 

Post Graduates in Life Sciences, Pharmacy, Statistics, Social Works, Sociology, BAMS, BSMS, with MD in AYUSH to support Intramural Primary Research co- ordination and facilitate in better central procurement planning framework at ICMR headquarters

ICMR-funded project entitled Clinical Development of IIIM- 290 CDK9T1 Inhibitor for Metastatic Pancreatic Cancer, tenable at CSIR-Indian Institute of Integrative Medicine, Jammu. Research experience in natural product chemistry will be preferred.